130 related articles for article (PubMed ID: 22037261)
1. Mesotheliomas with crystalloid structures: report of nine cases, including one with oncocytic features.
Ordóñez NG
Mod Pathol; 2012 Feb; 25(2):272-81. PubMed ID: 22037261
[TBL] [Abstract][Full Text] [Related]
2. Pleomorphic mesothelioma: report of 10 cases.
Ordóñez NG
Mod Pathol; 2012 Jul; 25(7):1011-22. PubMed ID: 22388762
[TBL] [Abstract][Full Text] [Related]
3. Mesothelioma with rhabdoid features: an ultrastructural and immunohistochemical study of 10 cases.
Ordóñez NG
Mod Pathol; 2006 Mar; 19(3):373-83. PubMed ID: 16400322
[TBL] [Abstract][Full Text] [Related]
4. Mesothelioma with clear cell features: an ultrastructural and immunohistochemical study of 20 cases.
Ordóñez NG
Hum Pathol; 2005 May; 36(5):465-73. PubMed ID: 15948112
[TBL] [Abstract][Full Text] [Related]
5. Macroscopic, histologic, histochemical, immunohistochemical, and ultrastructural features of mesothelioma.
Hammar SP
Ultrastruct Pathol; 2006; 30(1):3-17. PubMed ID: 16517466
[TBL] [Abstract][Full Text] [Related]
6. The potential utility of GATA binding protein 3 for diagnosis of malignant pleural mesotheliomas.
Prabhakaran S; Hocking A; Kim C; Hussey M; Klebe S
Hum Pathol; 2020 Nov; 105():1-8. PubMed ID: 32888937
[TBL] [Abstract][Full Text] [Related]
7. Unusual intraparenchymal growth patterns of malignant pleural mesothelioma.
Nind NR; Attanoos RL; Gibbs AR
Histopathology; 2003 Feb; 42(2):150-5. PubMed ID: 12558747
[TBL] [Abstract][Full Text] [Related]
8. Ultrastructural aspects of the histogenesis of diffuse and localized mesothelioma.
Dardick I; Srigley JR; McCaughey WT; van Nostrand AW; Ritchie AC
Virchows Arch A Pathol Anat Histopathol; 1984; 402(4):373-88. PubMed ID: 6426147
[TBL] [Abstract][Full Text] [Related]
9. Sarcomatoid mesothelioma and its histological mimics: a comparative immunohistochemical study.
Lucas DR; Pass HI; Madan SK; Adsay NV; Wali A; Tabaczka P; Lonardo F
Histopathology; 2003 Mar; 42(3):270-9. PubMed ID: 12605647
[TBL] [Abstract][Full Text] [Related]
10. Diffuse epithelial mesothelioma: a review of the ultrastructural spectrum.
Dardick I; Jabi M; McCaughey WT; Deodhare S; van Nostrand AW; Srigley JR
Ultrastruct Pathol; 1987; 11(5-6):503-33. PubMed ID: 3318058
[TBL] [Abstract][Full Text] [Related]
11. The immunohistochemical profile of malignant mesotheliomas of the tunica vaginalis: a study of 20 cases.
Winstanley AM; Landon G; Berney D; Minhas S; Fisher C; Parkinson MC
Am J Surg Pathol; 2006 Jan; 30(1):1-6. PubMed ID: 16330935
[TBL] [Abstract][Full Text] [Related]
12. Lymphohistiocytoid mesothelioma: a clinical, immunohistochemical and ultrastructural study of four cases and literature review.
Yao DX; Shia J; Erlandson RA; Klimstra DS
Ultrastruct Pathol; 2004; 28(4):213-28. PubMed ID: 15693633
[TBL] [Abstract][Full Text] [Related]
13. Usefulness of p16/CDKN2A fluorescence in situ hybridization and BAP1 immunohistochemistry for the diagnosis of biphasic mesothelioma.
Wu D; Hiroshima K; Yusa T; Ozaki D; Koh E; Sekine Y; Matsumoto S; Nabeshima K; Sato A; Tsujimura T; Yamakawa H; Tada Y; Shimada H; Tagawa M
Ann Diagn Pathol; 2017 Feb; 26():31-37. PubMed ID: 28038708
[TBL] [Abstract][Full Text] [Related]
14. Malignant mesothelioma with intracytoplasmic crystalline inclusions.
Goedhals J; Beukes CA; Cooper S
Ultrastruct Pathol; 2007; 31(1):73-6. PubMed ID: 17455100
[TBL] [Abstract][Full Text] [Related]
15. Value of mesothelin immunostaining in the diagnosis of mesothelioma.
Ordóñez NG
Mod Pathol; 2003 Mar; 16(3):192-7. PubMed ID: 12640097
[TBL] [Abstract][Full Text] [Related]
16. Lymphohistiocytoid mesothelioma: a rare lymphomatoid variant of predominantly sarcomatoid mesothelioma.
Henderson DW; Attwood HD; Constance TJ; Shilkin KB; Steele RH
Ultrastruct Pathol; 1988; 12(4):367-84. PubMed ID: 2458647
[TBL] [Abstract][Full Text] [Related]
17. BAP1 (BRCA1-associated protein 1) is a highly specific marker for differentiating mesothelioma from reactive mesothelial proliferations.
Cigognetti M; Lonardi S; Fisogni S; Balzarini P; Pellegrini V; Tironi A; Bercich L; Bugatti M; Rossi G; Murer B; Barbareschi M; Giuliani S; Cavazza A; Marchetti G; Vermi W; Facchetti F
Mod Pathol; 2015 Aug; 28(8):1043-57. PubMed ID: 26022455
[TBL] [Abstract][Full Text] [Related]
18. Malignant mesothelioma: ultrastructural distinction from adenocarcinoma.
Warhol MJ; Hickey WF; Corson JM
Am J Surg Pathol; 1982 Jun; 6(4):307-14. PubMed ID: 6287872
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical differentiation of sarcomatoid mesotheliomas from other spindle cell neoplasms.
Cagle PT; Truong LD; Roggli VL; Greenberg SD
Am J Clin Pathol; 1989 Nov; 92(5):566-71. PubMed ID: 2479255
[TBL] [Abstract][Full Text] [Related]
20. New Insights on Diagnostic Reproducibility of Biphasic Mesotheliomas: A Multi-Institutional Evaluation by the International Mesothelioma Panel From the MESOPATH Reference Center.
Galateau Salle F; Le Stang N; Nicholson AG; Pissaloux D; Churg A; Klebe S; Roggli VL; Tazelaar HD; Vignaud JM; Attanoos R; Beasley MB; Begueret H; Capron F; Chirieac L; Copin MC; Dacic S; Danel C; Foulet-Roge A; Gibbs A; Giusiano-Courcambeck S; Hiroshima K; Hofman V; Husain AN; Kerr K; Marchevsky A; Nabeshima K; Picquenot JM; Rouquette I; Sagan C; Sauter JL; Thivolet F; Travis WD; Tsao MS; Weynand B; Damiola F; Scherpereel A; Pairon JC; Lantuejoul S; Rusch V; Girard N
J Thorac Oncol; 2018 Aug; 13(8):1189-1203. PubMed ID: 29723687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
